VT News

Alan Robert Murray

Ask VT AI
View News Summary
  • Eli Lilly's weight-loss drug Zepbound outperforms Novo Nordisk's Wegovy in a clinical trial, demonstrating superior efficacy for obesity treatment.
  • Trump's transition team agrees to FBI vetting after initial resistance, a critical step for a smooth transition.
  • Supreme Court to rule on Tennessee's ban on gender-affirming care for transgender youth, a case that could impact transgender rights nationwide.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Eli Lilly's weight-loss drug Zepbound outperforms Novo Nordisk's Wegovy in a clinical trial, demonstrating superior efficacy for obesity treatment.
  • Trump's transition team agrees to FBI vetting after initial resistance, a critical step for a smooth transition.
  • Supreme Court to rule on Tennessee's ban on gender-affirming care for transgender youth, a case that could impact transgender rights nationwide.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Alan Robert Murray

Top Topics

Trending in U.S.

World

Sport